D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome
Polycystic ovarian syndrome (PCOS) is the main cause of female infertility. It is a multifactorial disorder with varying clinical manifestations including metabolic/endocrine abnormalities, hyperandrogenism, and ovarian cysts, among other conditions. D-<i>Chiro</i>-inositol (DCI) is the...
Main Authors: | Eva Pericuesta, Ricardo Laguna-Barraza, Priscila Ramos-Ibeas, Julia L. Gutierrez-Arroyo, Juan A. Navarro, Katia Vera, Carlos Sanjuan, Elena Baixeras, Fernando Rodríguez de Fonseca, Alfonso Gutierrez-Adan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6049 |
Similar Items
-
Results of treatment with myo-Inositol and D-chiro inositol combination in ratio 5:1 in women with polycystic ovary syndrome
by: Tatiana A. Oboskalova, et al.
Published: (2020-12-01) -
A comparative study of combination of Myo-inositol and D-chiro-inositol versus Metformin in the management of polycystic ovary syndrome in obese women with infertility
by: Sujana Thalamati
Published: (2020-12-01) -
Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review
by: Sergio Davinelli, et al.
Published: (2020-04-01) -
Inositol treatment for PCOS should be science-based and not arbitrary
by: S. Roseff, et al.
Published: (2020-11-01) -
The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
by: Hyun Yang, et al.
Published: (2022-07-01)